Related Articles
Clinical outcome of patients with inoperable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus Nab‑paclitaxel as a first‑line therapy: A retrospective analysis
Small-cell lung cancer with recurrent syncope as the initial symptom: A case report and literature review
Female gender may predict response to FOLFIRINOX in patients with unresectable pancreatic cancer: A single institution retrospective review
Comparing the cost-effectiveness of FOLFIRINOX, nab-paclitaxel plus gemcitabine, gemcitabine and S-1 for the treatment of metastatic pancreatic cancer
Hashimoto encephalopathy associated with hyperthyroidism: A case report